Clinical Trial

Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease

Study acronym: VRN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 13, 2024 (before its estimated June 11, 2025 completion). Its status may not reflect the trial's current state.
Summary
Behavioural and psychological symptoms of dementia (BPSD), such as depression affect up to 90% patients with dementia. Non-pharmacological treatment of BPSD, can be difficult to access, require caregiver support, travel, and often have long waiting lists. Virtual reality (VR) is an innovative, portable, immersive, and accessible technology which can be used in-home. More information is required on the feasibility of using VR in-home with older adults with dementia. Our study will offer a 4-week program of 15-minutes sessions, twice per week nature-based VR program for BPSD delivered in-home by virtual reality (VR). Additionally, caregivers will have the option of taking part in the study and provide feedback regarding the VR intervention. If successful, this project has the potential to prolong aging in place for individuals with BPSD, as BPSD is a significant factor in institutionalization.
Trial Details
NCT Number NCT06732128
Lead Sponsor Centre for Addiction and Mental Health
Collaborators: St. Mary's Research Center, Canada
Conditions Alzheimer Disease, Depression
Enrollment 50 participants
Start Date 2025-01-06
Primary Completion 2025-06-11 (estimated)
Study Completion 2025-11-11 (estimated)
Updated on ClinicalTrials.gov 2024-12-13